日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to "From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha"

更正“从发现到临床试验:YCT-529,一种靶向视黄酸受体α的口服非激素男性避孕药”

Shi, Rui; Al Noman, Md Abdullah; Mannowetz, Nadja; Cheryala, Narsihmulu; Haque, Ehfazul; Taher, Noha; Maitra, Soma; Naqvi, Tahmina; Chung, Sanny S W; Bakshi, Akash; Hawkinson, Jon E; Wong, Henry L; Wolgemuth, Debra J; Georg, Gunda I

From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha

从发现到临床试验:YCT-529,一种靶向视黄酸受体α的口服非激素男性避孕药

Shi, Rui; Al Noman, Md Abdullah; Mannowetz, Nadja; Cheryala, Narsihmulu; Haque, Ehfazul; Maitra, Soma; Naqvi, Tahmina; Chung, Sanny S W; Bakshi, Akash; Hawkinson, Jon E; Wong, Henry L; Wolgemuth, Debra J; Georg, Gunda I

Discovery of Focal Adhesion Kinase (FAK) activators to promote intestinal mucosal healing

发现黏着斑激酶 (FAK) 激活剂可促进肠黏膜愈合

Gallardo-Macias, Ricardo; Wang, Qinggang; Raafat Elsayed, Ahmed Adham; Liu, Guiming; Wong, Henry L; Georg, Gunda I; Basson, Marc D; Gurvich, Vadim J

Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

药物基因组学合成致死筛选揭示NF1相关肿瘤的潜在弱点和新的治疗方法

Williams, Kyle B; Larsson, Alex T; Keller, Bryant J; Chaney, Katherine E; Williams, Rory L; Bhunia, Minu M; Draper, Garrett M; Jubenville, Tyler A; Hudson, Wendy A; Georg, Gunda I; Moertel, Christopher L; Ratner, Nancy; Largaespada, David A

Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors

大环二氢吡啶类似物作为泛BET BD2优先抑制剂

Jiang, Jiewei; Liang, Taimeng; Solberg, Jonathan; Chan, Alice; Kalra, Prakriti; Shi, Rui; Pomerantz, William C K; Hawkinson, Jon E; Schönbrunn, Ernst; Georg, Gunda I

Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives

开发Na,K-ATPase-α4抑制剂作为男性避孕药的策略

Syeda, Shameem S; Sánchez, Gladis; McDermott, Jeffrey P; Cheryala, Narsihmulu; Wong, Henry L; Georg, Gunda I; Blanco, Gustavo

Identification of TSSK1 and TSSK2 as Novel Targets for Male Contraception

TSSK1 和 TSSK2 被鉴定为男性避孕的新靶点

Nayyab, Saman; Gervasi, Marıá Gracia; Tourzani, Darya A; Shamailova, Yeva; Akizawa, Hiroki; Taghavi, Mahboubeh; Cui, Wei; Fissore, Rafael; Salicioni, Ana Maria; Georg, Gunda I; Snyder, Elizabeth; Visconti, Pablo E

Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception

靶向细胞周期蛋白依赖性激酶 2 (CDK2) 与细胞周期蛋白和 Speedy 1 (Spy1) 的相互作用以治疗癌症和男性避孕

Giarolla, Jeanine; Holdaway, Kelsey A; Nazari, Maryam; Aiad, Laila; Sarkar, Bidisha; Georg, Gunda I

Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review

用于男性避孕的视黄酸受体α特异性拮抗剂YCT-529的研发:简要回顾

Shi, Rui; Wolgemuth, Debra J; Georg, Gunda I

Design of Tissue-Selective PROTACs Through Recruiting E3 Ligase Scaffolding Protein MAGEA11

通过募集 E3 连接酶支架蛋白 MAGEA11 设计组织选择性 PROTAC

Jacobsen, Isabella E; Shi, Rui; Scholtz, Cole R; Pomerantz, William C K; Georg, Gunda I